Jupiter Bioscience
JUPITER · Pharma > Pharmaceuticals & Drugs · Chairman: Venkat R Kalavakolanu · MD: Venkat R Kalavakolanu · Listing date: Jan. 9, 2010

Stock Price vs Company Growth
10y
0.0%
all
18.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 4.15 0%
N/A
4.15
Company Overview

Sales
168 Cr
Growth: -4.9%
Profit after Tax
-2.81 Cr
Growth: -112.1%
Micro Cap
26.9 Cr
P/S: 0.2x
Industry P/S: 3.1x
Fundamentals

Sales (Cr) ₹ 168
Growth -4.9%
EBITDA 39.2%
P/S 0.2x
Dividend 0.0%
P/E -2.4x
Book Value ₹ 115
PEG Ratio 0.5x
ROE -0.4%
P/B 0.0x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

Jupiter Bioscience is one of the few companies in the world to have competency in synthesis of peptides starting from the basic stage to finished peptides. The company was established in 1985 by K S Sarma a technocrat of repute and a respected entrepreneur in the Indian pharmaceutical industry. The company’s product portfolio further includes specialty and fine chemicals, drug intermediates, bulk drugs and nutraceuticals.
Followers (2)